136 related articles for article (PubMed ID: 26850828)
1. Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins.
Giamarellos-Bourboulis EJ; Tziolos N; Routsi C; Katsenos C; Tsangaris I; Pneumatikos I; Vlachogiannis G; Theodorou V; Prekates A; Antypa E; Koulouras V; Kapravelos N; Gogos C; Antoniadou E; Mandragos K; Armaganidis A;
Clin Microbiol Infect; 2016 Jun; 22(6):499-506. PubMed ID: 26850828
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.
Papadopoulos A; Ribera A; Mavrogenis AF; Rodriguez-Pardo D; Bonnet E; Salles MJ; Dolores Del Toro M; Nguyen S; Blanco-García A; Skaliczki G; Soriano A; Benito N; Petersdorf S; Pasticci MB; Tattevin P; Tufan ZK; Chan M; O'Connell N; Pantazis N; Kyprianou A; Pigrau C; Megaloikonomos PD; Senneville E; Ariza J; Papagelopoulos PJ; Giannitsioti E;
Int J Antimicrob Agents; 2019 Mar; 53(3):294-301. PubMed ID: 30395988
[TBL] [Abstract][Full Text] [Related]
3. Treatment with IgM-enriched immunoglobulin in sepsis: a matched case-control analysis.
Martinez JI; Sánchez HF; Velandia JA; Urbina Z; Florián MC; Martínez MA; Giamarellos-Bourboulis EJ; Pino-Pinzón CJ; Ortiz G; Celis E
J Crit Care; 2021 Aug; 64():120-124. PubMed ID: 33872918
[TBL] [Abstract][Full Text] [Related]
4. The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.
Ferstl PG; Filmann N; Brandt C; Zeuzem S; Hogardt M; Kempf VAJ; Müller M; Waidmann O; Reinheimer C
Liver Int; 2017 Oct; 37(10):1488-1496. PubMed ID: 28374901
[TBL] [Abstract][Full Text] [Related]
5. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
6. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.
Zilberberg MD; Shorr AF; Micek ST; Vazquez-Guillamet C; Kollef MH
Crit Care; 2014 Nov; 18(6):596. PubMed ID: 25412897
[TBL] [Abstract][Full Text] [Related]
7. Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial.
Giamarellos-Bourboulis EJ; Mylona V; Antonopoulou A; Tsangaris I; Koutelidakis I; Marioli A; Raftogiannis M; Kopterides P; Lymberopoulou K; Mouktaroudi M; Papageorgiou C; Papaziogas B; Georgopoulou AP; Tsaganos T; Papadomichelakis E; Gogos C; Ladas M; Savva A; Pelekanou A; Baziaka F; Koutoukas P; Kanni T; Spyridaki A; Maniatis N; Pelekanos N; Kotsaki A; Vaki I; Douzinas EE; Koratzanis G; Armaganidis A
J Antimicrob Chemother; 2014 Apr; 69(4):1111-8. PubMed ID: 24292991
[TBL] [Abstract][Full Text] [Related]
8. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome.
Dimitriades K; Morrow BM; Jeena P
Arch Dis Child; 2014 Mar; 99(3):262-6. PubMed ID: 24170687
[TBL] [Abstract][Full Text] [Related]
11. Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial.
Kalvelage C; Zacharowski K; Bauhofer A; Gockel U; Adamzik M; Nierhaus A; Kujath P; Eckmann C; Pletz MW; Bracht H; Simon TP; Winkler M; Kindgen-Milles D; Albertsmeier M; Weigand M; Ellger B; Ragaller M; Ullrich R; Marx G
Trials; 2019 Mar; 20(1):156. PubMed ID: 30832742
[TBL] [Abstract][Full Text] [Related]
12. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
14. The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia.
Kwa AL; Low JG; Lee E; Kurup A; Chee HL; Tam VH
Diagn Microbiol Infect Dis; 2007 May; 58(1):99-104. PubMed ID: 17300905
[TBL] [Abstract][Full Text] [Related]
15. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital.
Chaisathaphol T; Chayakulkeeree M
J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S35-45. PubMed ID: 24772579
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for tracheobronchial acquisition of resistant Gram-negative bacterial pathogens in mechanically ventilated ICU patients.
Papakonstantinou I; Angelopoulos E; Baraboutis I; Perivolioti E; Parisi M; Psaroudaki Z; Kampisiouli E; Argyropoulou A; Nanas S; Routsi C
J Chemother; 2015 Oct; 27(5):283-9. PubMed ID: 24981117
[TBL] [Abstract][Full Text] [Related]
18. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections.
Dortch MJ; Fleming SB; Kauffmann RM; Dossett LA; Talbot TR; May AK
Surg Infect (Larchmt); 2011 Feb; 12(1):15-25. PubMed ID: 21091186
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
[TBL] [Abstract][Full Text] [Related]
20. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.
Fitzpatrick JM; Biswas JS; Edgeworth JD; Islam J; Jenkins N; Judge R; Lavery AJ; Melzer M; Morris-Jones S; Nsutebu EF; Peters J; Pillay DG; Pink F; Price JR; Scarborough M; Thwaites GE; Tilley R; Walker AS; Llewelyn MJ;
Clin Microbiol Infect; 2016 Mar; 22(3):244-51. PubMed ID: 26577143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
